Journal of Research in Medical Sciences 2018. 23(10):J Res Med Sci 2018, 23:93 (26 October 2018).
Serum levels of interleukin-1 beta associate better with severity of simple steatosis than liver function tests in morbidly obese patients
Background: In high?fat diet?fed mice, interleukin?1 beta (IL?1 beta) has been shown to play a key role in hepatic steatosis. However, it remains unknown whether IL?1 beta could be associated with different grades of steatosis in obese humans. Materials and Methods: Morbidly obese patients (n = 124) aged 18–65 years were divided into four groups: no steatosis (controls), mild steatosis, moderate steatosis, and severe steatosis using abdominal ultrasound. IL?1 beta serum levels and liver function tests were measured and signifcant di?erences were estimated by one?way ANOVA followed by Tukey test. Results: IL?1 beta serum levels signifcantly increased in morbidly obese patients with mild (11.38 ± 2.40 pg/ml), moderate (16.72 ± 2.47 pg/ml), and severe steatosis (23.29 ± 5.2 pg/ml) as compared to controls (7.78 ± 2.26 pg/ml). Liver function tests did not signifcantly change among di?erent grades of steatosis. Conclusion: IL?1 beta serum levels associate better with steatosis degree than liver function tests in morbidly obese population.
Fatty liver, interleukin?1 beta, liver functions tests, morbid, obesity
This article has been downloaded 0 times up to now.
This work is licensed under a Creative Commons Attribution 3.0 License